s condition.

A study of the relationship between dasatinib medication for chronic myeloid leukemia in chronic phase and vascular endothelial function related and immunological parameters.

Prospective study of I-131 3-iodobenzylguanidine radiotherapy for high-risk neuroblastoma; in accordance with the Japanese Advanced Medical Care B program for the anticancer drug with high medical needs.